MS-DRG v44.0 · MDC 13: Diseases and Disorders of the Female Reproductive System
731 — Uterine and Adnexa Procedures for Malignancy with MCC
- Relative weight
- 3.5478
- Geometric mean LOS
- 5.6 days
- Arithmetic mean LOS
- 8.4 days
- Type
- Surgical
About MS-DRG 731
MS-DRG 731, Uterine and Adnexa Procedures for Malignancy with MCC, is a surgical DRG in MDC 13 (Diseases and Disorders of the Female Reproductive System) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.
Its FY2027 relative weight is 3.5478, so Medicare's base payment for this DRG is about 3.55 times the average inpatient case, before hospital-specific adjustments. The geometric mean length of stay is 5.6 days and the arithmetic mean is 8.4 days.
It belongs to a 3-level severity family: DRG 731 (with MCC, weight 3.5478), DRG 732 (with CC, weight 1.9208) and DRG 733 (without CC/MCC, weight 1.4324). The highest-severity level carries 2.5 times the weight of the lowest, which is why documenting CC and MCC conditions matters.
58 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.
ICD-10-CM codes that group to DRG 731 (58)
Chapter 2: Neoplasms
- C51.0Malignant neoplasm of labium majus
- C51.1Malignant neoplasm of labium minus
- C51.2Malignant neoplasm of clitoris
- C51.8Malignant neoplasm of overlapping sites of vulva
- C51.9Malignant neoplasm of vulva, unspecified
- C52Malignant neoplasm of vagina
- C53.0Malignant neoplasm of endocervix
- C53.1Malignant neoplasm of exocervix
- C53.8Malignant neoplasm of overlapping sites of cervix uteri
- C53.9Malignant neoplasm of cervix uteri, unspecified
- C54.0Malignant neoplasm of isthmus uteri
- C54.1Malignant neoplasm of endometrium
- C54.2Malignant neoplasm of myometrium
- C54.3Malignant neoplasm of fundus uteri
- C54.8Malignant neoplasm of overlapping sites of corpus uteri
- C54.9Malignant neoplasm of corpus uteri, unspecified
- C55Malignant neoplasm of uterus, part unspecified
- C56.1Malignant neoplasm of right ovary
- C56.2Malignant neoplasm of left ovary
- C56.3Malignant neoplasm of bilateral ovaries
- C56.9Malignant neoplasm of unspecified ovary
- C57.00Malignant neoplasm of unspecified fallopian tube
- C57.01Malignant neoplasm of right fallopian tube
- C57.02Malignant neoplasm of left fallopian tube
- C57.10Malignant neoplasm of unspecified broad ligament
- C57.11Malignant neoplasm of right broad ligament
- C57.12Malignant neoplasm of left broad ligament
- C57.20Malignant neoplasm of unspecified round ligament
- C57.21Malignant neoplasm of right round ligament
- C57.22Malignant neoplasm of left round ligament
- C57.3Malignant neoplasm of parametrium
- C57.4Malignant neoplasm of uterine adnexa, unspecified
- C57.7Malignant neoplasm of other specified female genital organs
- C57.8Malignant neoplasm of overlapping sites of female genital organs
- C57.9Malignant neoplasm of female genital organ, unspecified
- C58Malignant neoplasm of placenta
- C76.3Malignant neoplasm of pelvis
- C79.60Secondary malignant neoplasm of unspecified ovary
- C79.61Secondary malignant neoplasm of right ovary
- C79.62Secondary malignant neoplasm of left ovary
- C79.63Secondary malignant neoplasm of bilateral ovaries
- C79.82Secondary malignant neoplasm of genital organs
- D06.0Carcinoma in situ of endocervix
- D06.1Carcinoma in situ of exocervix
- D06.7Carcinoma in situ of other parts of cervix
- D06.9Carcinoma in situ of cervix, unspecified
- D07.0Carcinoma in situ of endometrium
- D07.1Carcinoma in situ of vulva
- D07.2Carcinoma in situ of vagina
- D07.30Carcinoma in situ of unspecified female genital organs
- D07.39Carcinoma in situ of other female genital organs
- D39.0Neoplasm of uncertain behavior of uterus
- D39.10Neoplasm of uncertain behavior of unspecified ovary
- D39.11Neoplasm of uncertain behavior of right ovary
- D39.12Neoplasm of uncertain behavior of left ovary
- D39.2Neoplasm of uncertain behavior of placenta
- D39.8Neoplasm of uncertain behavior of other specified female genital organs
- D39.9Neoplasm of uncertain behavior of female genital organ, unspecified
Common questions about DRG 731
What is the relative weight of DRG 731?
- 3.5478 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.
What is the average length of stay for DRG 731?
- The geometric mean length of stay is 5.6 days; the arithmetic mean is 8.4 days.
Is DRG 731 medical or surgical?
- DRG 731 is a surgical DRG.